BriaCell Therapeutics Corp. (BCTXL) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.20M | +18.4% |
| 2024 | -$33.33M | -43.2% |
| 2023 | -$23.27M | -52.2% |
| 2022 | -$15.29M | -119.2% |
| 2021 | -$6.98M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$27.20M | +18.4% |
| 2024 | -$33.33M | -43.2% |
| 2023 | -$23.27M | -52.2% |
| 2022 | -$15.29M | -119.2% |
| 2021 | -$6.98M | — |